MRS 2500 is a highly potent and selective P2Y1 receptor antagonist, widely utilized in research and preclinical pharmacology for its significant antiplatelet and antithrombotic properties. Pharmaceutical… Read more
MRS 2500 is a highly potent and selective P2Y1 receptor antagonist, widely utilized in research and preclinical pharmacology for its significant antiplatelet and antithrombotic properties. Pharmaceutical laboratories rely on accurate reference standards of this compound to support rigorous analytical workflows. By incorporating well-characterized MRS 2500-related impurities, active metabolites, and stable isotope-labelled compounds into their testing protocols, researchers can achieve precise impurity profiling and reliable method validation. These specialized reference materials are essential for the sensitive detection, identification, and quantification of target analytes during drug development and quality control. Providing high-quality standards ensures consistency and accuracy when monitoring complex chemical structures in pharmaceutical research, enabling robust performance in quantitative analysis and stability studies.